Lataa...
Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor
The discovery in the 1980s that protein kinase C (PKC) is a receptor for the tumor-promoting phorbol esters fueled the dogma that PKC is an oncoprotein. Yet 30+ years of clinical trials for cancer using PKC inhibitors not only failed, but in some instances worsened patient outcome. The recent analys...
Tallennettuna:
| Julkaisussa: | Trends Pharmacol Sci |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5403564/ https://ncbi.nlm.nih.gov/pubmed/28283201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2017.02.002 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|